Table 1 Demographic and clinical characteristics of study participants (n = 408)
Characteristics | |
|---|---|
Age (year), mean ± SD | 37 ± 10.3 |
Age group, n (%) | |
18–34 | 169 (41.4) |
35–45 | 161 (39.5) |
> 45 | 78 (19.1) |
Sex, n (%) | |
Male | 135 (33.1) |
Female | 273 (66.9) |
Residence, n (%) | |
Rural | 88 (21.6) |
Urban | 320 (78.4) |
Education, n (%) | |
< High school | 240 (58.8) |
≥ High school | 168 (41.2) |
Duration of infection, n (%) | |
≤ 5 years | 227 (55.6) |
> 5 years | 181 (44.4) |
Duration on ART, n (%) | |
≤ 5 years | 145 (35.5) |
> 5 years | 263 (64.5) |
ART regimen, n (%) | |
AZT + 3TC + EFV | 66 (16.2) |
TDF + 3TC + NVP | 71 (17.4) |
AZT + 3TC + NVP | 84 (20.6) |
TDF + 3TC + EFV | 76 (18.6) |
Other | 111 (27.2) |
Current smoker, n (%) | 16 (3.9) |
Alcohol consumers, n (%) | 62 (15.2) |
Family history of DM, n (%) | 42 (10.3). |
Body mass index (kg/m2), mean ± SD | 20.40 ± 2.11 |
Systolic BP (mmHg), mean ± SD | 127.2 ± 12.8 |
Diastolic BP (mmHg), mean ± SD | 82.0 ± 6.0 |
Hypertension, n (%) | 121 (29.7) |
CD4 count (cell/mm3), mean ± SD | 343.1 ± 311.6 |
Fasting plasma glucose (mg/dl), mean ± SD | 105.7 ± 39.0 |